BPA in the environment is as pernicious as it is ubiquitous.

BPA can be found in products such as the lining of cans, baby bottles, plastic drinking containers and toilette paper.

Findings in a recent peer reviewed study indicate that BPA should be considered a risk factor for metabolic disorders in humans.

BPA has been considered a weak estrogen because of its low binding affinity to two types of estrogen receptors which work in the endocrine system in the synthesis of insulin within the pancreas.

Among many other complex functions of the cells including the release of energy as glucose, the development of Type 2 diabetes has been seen to increase when BPA is present.

In addition it may provoke insulin resistance in liver and skeletal muscle together with β-cell exhaustion, contributing to the development of type-2 diabetes [1]. Alterations of glucose and lipid metabolism by BPA in adults may constitute a significant hazard during pregnancy for both mothers and offspring as demonstrated in mice and rats